{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:54:41Z","timestamp":1780318481287,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003999","name":"Science Fund for Creative Research Groups","doi-asserted-by":"publisher","award":["B2021201038"],"award-info":[{"award-number":["B2021201038"]}],"id":[{"id":"10.13039\/501100003999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["20220484207"],"award-info":[{"award-number":["20220484207"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["32030060"],"award-info":[{"award-number":["32030060"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1201000"],"award-info":[{"award-number":["2021YFA1201000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2605003"],"award-info":[{"award-number":["2023YFC2605003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFE0106900"],"award-info":[{"award-number":["2021YFE0106900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005085","name":"Beijing Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51861135103"],"award-info":[{"award-number":["51861135103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171394"],"award-info":[{"award-number":["32171394"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32101148"],"award-info":[{"award-number":["32101148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102204"],"award-info":[{"award-number":["82102204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fundamental Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.fmre.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T21:08:00Z","timestamp":1742332080000},"page":"1920-1929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor suppressor protein-inspired peptide for siRNA delivery and synergistic cancer therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Julien Milon","family":"Essola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huining","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-1705","authenticated-orcid":false,"given":"Xing-Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3935-7245","authenticated-orcid":false,"given":"Yuanyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.fmre.2025.03.006_bib0001","article-title":"Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy","author":"Huang","year":"2022","journal-title":"Exploration"},{"issue":"37","key":"10.1016\/j.fmre.2025.03.006_bib0002","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","article-title":"RNAi therapeutic and its innovative biotechnological evolution","author":"Weng","year":"2019","journal-title":"Biotechnol. Adv."},{"issue":"5","key":"10.1016\/j.fmre.2025.03.006_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: State of the art","author":"Hu","year":"2020","journal-title":"Sign. Transduct. Targ. Ther."},{"issue":"18","key":"10.1016\/j.fmre.2025.03.006_bib0004","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fmre.2025.03.006_bib0005","article-title":"Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma","author":"Yang","year":"2024","journal-title":"Exploration"},{"issue":"18","key":"10.1016\/j.fmre.2025.03.006_bib0006","first-page":"193","article-title":"Targeting XKR8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy","author":"Chen","year":"2022","journal-title":"Nat Nanotechnol"},{"issue":"29","key":"10.1016\/j.fmre.2025.03.006_bib0007","article-title":"Virus-mimicking chimaeric polymersomes boost targeted cancer siRNA therapy in vivo","author":"Zou","year":"2017","journal-title":"Adv. Mater."},{"issue":"35","key":"10.1016\/j.fmre.2025.03.006_bib0008","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"35","key":"10.1016\/j.fmre.2025.03.006_bib0009","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"21","key":"10.1016\/j.fmre.2025.03.006_bib0010","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1021\/acs.nanolett.0c04468","article-title":"Core role of hydrophobic core of polymeric nanomicelle in endosomal escape of siRNA","author":"Li","year":"2021","journal-title":"Nano Lett."},{"issue":"17","key":"10.1016\/j.fmre.2025.03.006_bib0011","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: Immune responses to viral vectors","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.fmre.2025.03.006_bib0012","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nantod.2015.06.008","article-title":"15 years on siRNA delivery: Beyond the State-of-the-art on inorganic nanoparticles for RNAi therapeutics","author":"Conde","year":"2015","journal-title":"Nano Today"},{"issue":"136","key":"10.1016\/j.fmre.2025.03.006_bib0013","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"34","key":"10.1016\/j.fmre.2025.03.006_bib0014","article-title":"Photoactivatable silencing extracellular vesicle (PASEV) sensitizes cancer immunotherapy","author":"Lu","year":"2022","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.fmre.2025.03.006_bib0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ncomms1952","article-title":"Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems","author":"Kondo","year":"2012","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.fmre.2025.03.006_bib0016","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/onc.2010.614","article-title":"p16(Ink4a) overexpression in cancer: A tumor suppressor gene associated with senescence and high-grade tumors","author":"Romagosa","year":"2011","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.fmre.2025.03.006_bib0017","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1007548826495","article-title":"Cationic polymer based gene delivery systems","author":"Smedt","year":"2000","journal-title":"Pharm. Res."},{"issue":"210","key":"10.1016\/j.fmre.2025.03.006_bib0018","article-title":"New insights on the mechanism of polyethylenimine transfection and their implications on gene therapy and DNA vaccines","author":"Sabin","year":"2022","journal-title":"Coll. Surf. B: Biointerf."},{"issue":"12","key":"10.1016\/j.fmre.2025.03.006_bib0019","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/cells12010187","article-title":"Multiple roles of PLK1 in mitosis and meiosis","author":"Kalous","year":"2023","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.fmre.2025.03.006_bib0020","first-page":"65","article-title":"Polo-like kinases (Plks), a key regulator of cell cycle and new potential target for cancer therapy","author":"Lee","year":"2014","journal-title":"Developm. Reproduct."},{"issue":"6","key":"10.1016\/j.fmre.2025.03.006_bib0021","first-page":"60","article-title":"Transcriptional control of mitosis: Deregulation and cancer","author":"Nath","year":"2015","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"14","key":"10.1016\/j.fmre.2025.03.006_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13008-019-0058-4","article-title":"The essentiality landscape of cell cycle related genes in human pluripotent and cancer cells","author":"Viner-Breuer","year":"2019","journal-title":"Cell Div."},{"issue":"24","key":"10.1016\/j.fmre.2025.03.006_bib0023","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1634\/theoncologist.2018-0838","article-title":"An open-label, multicenter, phase i, dose escalation study with phase II expansion cohort to determine the safety, pharmacokinetics, and preliminary antitumor activity of intravenous TKM-080301 in subjects with advanced hepatocellular carcinoma","author":"Dika","year":"2019","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.fmre.2025.03.006_bib0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tranon.2015.03.010","article-title":"Targeting Polo-like kinases: A promising therapeutic approach for cancer treatment","author":"Liu","year":"2015","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.fmre.2025.03.006_bib0025","article-title":"Stimuli-responsive crosslinked nanomedicine for cancer treatment","author":"Xue","year":"2022","journal-title":"Exploration"},{"issue":"35","key":"10.1016\/j.fmre.2025.03.006_bib0026","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.biomaterials.2013.09.060","article-title":"The enhanced immune response of hepatitis B virus DNA vaccine using SiO@LDH nanoparticles as an adjuvant","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.fmre.2025.03.006_bib0027","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.7150\/thno.20297","article-title":"The pH-triggered triblock nanocarrier enabled highly efficient siRNA delivery for cancer therapy","author":"Du","year":"2017","journal-title":"Theranostics"},{"issue":"509","key":"10.1016\/j.fmre.2025.03.006_bib0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2016.05.030","article-title":"Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide","author":"Konate","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"123","key":"10.1016\/j.fmre.2025.03.006_bib0029","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1021\/acs.jpcb.9b07031","article-title":"Polyethylenimine-DNA ratio strongly affects their nanoparticle formation: A large-scale coarse-grained molecular dynamics study","author":"Mahajan","year":"2019","journal-title":"J. Phys. Chem. B"},{"issue":"34","key":"10.1016\/j.fmre.2025.03.006_bib0030","article-title":"Two-pronged intracellular co-delivery of antigen and adjuvant for synergistic cancer immunotherapy","author":"Meng","year":"2022","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.fmre.2025.03.006_bib0031","doi-asserted-by":"crossref","first-page":"eabp9435","DOI":"10.1126\/sciadv.abp9435","article-title":"Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases","author":"Wan","year":"2022","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.fmre.2025.03.006_bib0032","article-title":"Targeting lipid rafts as a strategy against coronavirus","author":"Sorice","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.fmre.2025.03.006_bib0033","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41420-023-01667-9","article-title":"PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability","author":"Peng","year":"2023","journal-title":"Cell Death Discov."},{"issue":"71","key":"10.1016\/j.fmre.2025.03.006_bib0034","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2015.02.015","article-title":"Effects of cell-penetrating peptides on transduction efficiency of PEGylated adenovirus","author":"Nigatu","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"55","key":"10.1016\/j.fmre.2025.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","author":"Frankel","year":"1988","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.fmre.2025.03.006_bib0036","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1525-0016(03)00135-7","article-title":"Cell surface adherence and endocytosis of protein transduction domains","author":"Lundberg","year":"2003","journal-title":"Molec. Ther."},{"issue":"84","key":"10.1016\/j.fmre.2025.03.006_bib0037","first-page":"585","article-title":"Cell-penetrating peptides: A re-evaluation of the mechanism of cellular uptake","author":"Richard","year":"2003","journal-title":"Biophys. J."},{"issue":"101","key":"10.1016\/j.fmre.2025.03.006_bib0038","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2016.05.041","article-title":"Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer","author":"Brinkman","year":"2016","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.fmre.2025.03.006_bib0039","article-title":"Deformable nanocarriers for enhanced drug delivery and cancer therapy","author":"Cao","year":"2024","journal-title":"Exploration"},{"issue":"77","key":"10.1016\/j.fmre.2025.03.006_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/bip.20170","article-title":"DNA-polycation complexation and polyplex stability in the presence of competing polyanions","author":"Danielsen","year":"2005","journal-title":"Biopolymers"},{"issue":"19","key":"10.1016\/j.fmre.2025.03.006_bib0041","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.2174\/0929867311209024929","article-title":"Role of generation, architecture, pH and ionic strength on successful siRNA delivery and transfection by hybrid PPV-PAMAM dendrimers","author":"Pavan","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.fmre.2025.03.006_bib0042","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1021\/acsnano.8b02830","article-title":"The blood clearance kinetics and pathway of polymeric micelles in cancer drug delivery","author":"Sun","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.fmre.2025.03.006_bib0043","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nano.2010.07.005","article-title":"Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery","author":"Kwok","year":"2011","journal-title":"Nanomed.-Nanotechnol. Biol. Med."},{"issue":"18","key":"10.1016\/j.fmre.2025.03.006_bib0044","article-title":"Enhanced intracellular delivery of siRNA by controlling ATP-responsivity of phenylboronic acid-functionalized polyion complex micelles","author":"Naito","year":"2018","journal-title":"Macromol. Biosci."},{"issue":"10","key":"10.1016\/j.fmre.2025.03.006_bib0045","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.apsb.2020.02.001","article-title":"Impact of molecular weight on the mechanism of cellular uptake of polyethylene glycols (PEGs) with particular reference to P-glycoprotein","author":"Wang","year":"2020","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"2011","key":"10.1016\/j.fmre.2025.03.006_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/414729","article-title":"Mechanisms of cellular uptake of cell-penetrating peptides","author":"Madani","year":"2011","journal-title":"J. Biophys."},{"issue":"43","key":"10.1016\/j.fmre.2025.03.006_bib0047","first-page":"147","article-title":"Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update","author":"Gauthier","year":"2012","journal-title":"Hepatol. Res."},{"issue":"31","key":"10.1016\/j.fmre.2025.03.006_bib0048","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/aps.2010.124","article-title":"Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation","author":"Tan","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.fmre.2025.03.006_bib0049","article-title":"Keeping up with the COVID's\u2014Could siRNA-based antivirals be a part of the answer?","author":"Forgham","year":"2022","journal-title":"Exploration"},{"issue":"35","key":"10.1016\/j.fmre.2025.03.006_bib0050","article-title":"Elaborately engineering of lipid nanoparticle for targeting delivery of siRNA and suppressing acute liver injury","author":"Wang","year":"2024","journal-title":"Chin. Chem. Letters"}],"container-title":["Fundamental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266732582500113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266732582500113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:34:48Z","timestamp":1778931288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266732582500113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S266732582500113X"],"URL":"https:\/\/doi.org\/10.1016\/j.fmre.2025.03.006","relation":{},"ISSN":["2667-3258"],"issn-type":[{"value":"2667-3258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor suppressor protein-inspired peptide for siRNA delivery and synergistic cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Fundamental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fmre.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}